Skip to Content
Merck
  • Threonine ADP-Ribosylation of Ubiquitin by a Bacterial Effector Family Blocks Host Ubiquitination.

Threonine ADP-Ribosylation of Ubiquitin by a Bacterial Effector Family Blocks Host Ubiquitination.

Molecular cell (2020-04-25)
Fujie Yan, Chunfeng Huang, Xiaofei Wang, Jiaxing Tan, Sen Cheng, Muyang Wan, Zhao Wang, Shuangyu Wang, Shuhui Luo, Arong Li, Xing Guo, Mingguang Feng, Xiaoyun Liu, Yongqun Zhu, Yan Zhou
ABSTRACT

Ubiquitination is essential for numerous eukaryotic cellular processes. Here, we show that the type III effector CteC from Chromobacterium violaceum functions as an adenosine diphosphate (ADP)-ribosyltransferase that specifically modifies ubiquitin via threonine ADP-ribosylation on residue T66. The covalent modification prevents the transfer of ubiquitin from ubiquitin-activating enzyme E1 to ubiquitin-conjugating enzyme E2, which inhibits subsequent ubiquitin activation by E2 and E3 enzymes in the ubiquitination cascade and leads to the shutdown of polyubiquitin synthesis in host cells. This unique modification also causes dysfunction of polyubiquitin chains in cells, thereby blocking host ubiquitin signaling. The disruption of host ubiquitination by CteC plays a crucial role in C. violaceum colonization in mice during infection. CteC represents a family of effector proteins in pathogens of hosts from different kingdoms. All the members of this family specifically ADP-ribosylate ubiquitin. The action of CteC reveals a new mechanism for interfering with host ubiquitination by pathogens.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Nicotinamide 1,N6-ethenoadenine dinucleotide, ≥98%